ImmunityBio vs Kite Pharma
ImmunityBio vs Kite Pharma, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ImmunityBio is on 44/100 and Kite Pharma on 66/100.
Where each one leads
ImmunityBio
Leads on none of the measures we hold for both companies.
Kite Pharma
- our overall score: 66/100 against 44/100
- agent readiness: 35/100 against 26/100
- domain rating: 62/100 against 53/100
- funding raised: $421M against $75.0M
At a glance
| Measure | ImmunityBio | Kite Pharma |
|---|---|---|
| What it is | A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases. | Biotechnology company developing and commercializing cell therapies for cancer treatment. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Immunotherapy | Biotechnology, Pharmaceuticals, Oncology, Cell Therapy |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2014 | 2009 |
| Headquarters | Culver City, USA | Santa Monica, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | ImmunityBio | Kite Pharma |
|---|---|---|
| Employees | 620 | Not published |
| Total funding | $75.0M | $421M |
| Latest round | Funding Round | Venture |
| Valuation | $1.1B | Not published |
| LinkedIn followers | 32,397 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | ImmunityBio | Kite Pharma |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 44/100 | 66/100 |
| Traction | 59/100 | 40/100 |
| Team | 30/100 | 80/100 |
| Search visibility | 33/100 | 15/100 |
| Quality | 45/100 | 90/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (26/100) | F (35/100) |
| Domain ratingLink authority, 0-100 | 53/100 | 62/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | ImmunityBio | Kite Pharma |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Bootstrap | Tailwind CSS, Bootstrap |
| Analytics | Google Tag Manager, Facebook Pixel | Google Tag Manager |
| Support stack | HubSpot | Not detected |
ImmunityBio vs Kite Pharma: common questions
Which is better, ImmunityBio or Kite Pharma?
On our 0-100 score Kite Pharma rates higher (66/100 against 44/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do ImmunityBio and Kite Pharma compare on the numbers?
Kite Pharma leads on our overall score (66/100 against 44/100), agent readiness (35/100 against 26/100), domain rating (62/100 against 53/100), funding raised ($421M against $75.0M).
Read the full ImmunityBio review and pricing or the Kite Pharma review and pricing. You can also browse other ImmunityBio alternatives we track.